Novo Nordisk to initiate study assessing CagriSema vs TirzepatideNovo Nordisk is planning a study that will see CagriSema, a new investigational medicine developed by Novo that combines Cagrilintide and...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatment3 days ago